Chemed (CHE) Other Accumulated Expenses (2009 - 2026)

Chemed (CHE) has reported Other Accumulated Expenses for 18 consecutive years, with $60.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 7.5% year-over-year to $60.8 million; the TTM figure through Mar 2026 stood at $60.8 million (down 7.5% YoY), while the FY2025 annual figure was $62.1 million, up 9.44% from the prior year.
• Other Accumulated Expenses came in at $60.8 million for Q1 2026 at Chemed, down from $62.1 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $69.3 million in Q1 2023, with the low at $640000.0 in Q2 2024.
• Average Other Accumulated Expenses over 5 years is $41.7 million, with a median of $55.3 million recorded in 2023.
• Across the five-year window, Other Accumulated Expenses tumbled 97.74% in 2022 and jumped 8375.96% in 2023, its largest moves.
• Year by year, Other Accumulated Expenses stood at $4.5 million in 2022, then jumped by 1147.17% to $55.6 million in 2023, then advanced by 2.03% to $56.7 million in 2024, then grew by 9.44% to $62.1 million in 2025, then retreated by 2.0% to $60.8 million in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $60.8 million, $62.1 million, and $65.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.